51 results
PRE 14A
LRMR
Larimar Therapeutics Inc
12 Apr 24
Preliminary proxy
6:06am
Governance Committee
CORPORATE GOVERNANCE HIGHLIGHTS
The following table summarizes our current Board structure and key elements of our corporate … governance framework:
GOVERNANCE ITEMS
Size of Board (set by the Board)
Number of Independent Directors
Independent Chairperson of the Board
Yes
Board
8-K
kh3 yd9z4730x
3 Oct 23
Departure of Directors or Certain Officers
4:31pm
10-K/A
fbfje
29 Apr 16
Annual report (amended)
12:00am
8-K
sqgdnvgpbaco
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
PREM14A
816q8l6c
6 Mar 20
Preliminary proxy related to merger
5:32pm
PRER14A
2uaodl28 3wc
10 Apr 20
Preliminary revised proxy
4:38pm
DEFM14A
wki99ynufpvjt5
29 Apr 20
Proxy related to merger
3:20pm
8-K
EX-10.1
x11ut22b7mm15x02q
12 Oct 17
Zafgen Appoints Jeffrey Hatfield as Chief Executive Officer; Thomas Hughes, Ph.D. to Continue as President, Appointed Chief Scientific Officer
12:00am
8-K
EX-14.1
0n1gt570b3v2nh7x2b
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
S-1
nz0wuoli8 ztv7ft
18 Apr 14
IPO registration
12:00am
424B4
5xchzkfic0k0j n3l
19 Jun 14
Prospectus supplement with pricing info
12:00am